The use of potassium-competitive acid blockers or PPI with clopidogrel is associated with a higher risk for ischemic events after stroke than clopidogrel alone, a new study shows.
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...